Thor Medical ASA

kr 4.12As of Sun 8 Nov 2026, 12:00 UTC
OSL:TRMEDHealthcare
Country Norway
PE (Fwd) •••
TSR 3Y CAGR 31.66%
Div yield —
ROE (18.79%)
Biotechnology
Beta (5Y) 0.02
PE TTM —
TSR TTM 15.27%
Mkt cap kr 1.739B
ROIC (9.13%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 4.64
12.71%
24.74%
Hold 7|1|8|0|4
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.09
0.09
0.09
0.09
12.78%
14.84%
19.27%
19.27%
Revenuekr M
232.5
245.3
259.3
265.2
14.24%
15.15%
15.52%
20.02%
Peers (US$183.9M)
Cap (US$)
PE
297.5M
—
184.3M
5.939x
Capital
TTM
5Y
10Y
Leveragex
5.454
(0.509)
(0.460)
EBIT/Intx
0.643
0.449
0.429
Own earn%
199.61
(18.81)
(21.21)
Sh yield%
24.40
52.06
51.26
Owners
Insiders/Inst%
3.83
87.83
Short interest%
4.67
SBC / revenue%
1.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
21–34
$1 testx
—
Incr. ROIC%
8